Clinical Trials Directory

Trials / Unknown

UnknownNCT05807581

Clinical, Molecular and Electrophysiological Profiling of Parkinson's Disease: the Role of Non-pharmacological Therapies

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In Parkinson's disease (PD), direct evidence linking inflammation to the harmful activities of alpha-synuclein (a-syn) aggregates, the disease onset, and its progression is still lacking. This translational project aims to reveal the causal relationship between a-syn and inflammation. The investigators will also investigate the mechanisms underlying the beneficial effects of two non-pharmacological approaches, motor exercise and neuromodulation, with particular focus on neuroinflammation and brain-derived neurotrophic factor (BDNF) production. the investigators will investigate the molecular pathways and synaptic alterations underlying disease progression. This will be paralleled by a clinical study, in which clinical assessment will be associated with cerebrospinal fluid (CSF) and blood neurodegeneration and inflammatory biomarkers measures. Then, the investigators will test the hypothesis that intensive exercise and neuromodulation may reduce neuroinflammation and a-syn spreading via the activation of BDNF-related pathways.

Conditions

Interventions

TypeNameDescription
OTHERphysical activitytreadmill running 3 times weekly
OTHERiTBSrepetitive TMS stimulation 5 days weekly for two weeks

Timeline

Start date
2023-06-09
Primary completion
2025-05-30
Completion
2025-05-30
First posted
2023-04-11
Last updated
2024-03-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05807581. Inclusion in this directory is not an endorsement.